Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Prepaid Assets of $3.0 million for Q4 2025, down 16.92% year-over-year from $3.6 million in Q4 2024, and down 8.75% quarter-over-quarter from $3.3 million in Q3 2025.
Corbus Pharmaceuticals Holdings (CRBP) Prepaid Assets (2013 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Prepaid Assets history runs 13 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Prepaid Assets fell 16.92% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 16.92% YoY), while the FY2025 annual figure was $3.0 million, down 16.92% from the prior year.
- Prepaid Assets for Q4 2025 stood at $3.0 million, down from $3.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $5.9 million in Q2 2025, with the low at $791616.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $2.2 million (2022), against an average of $2.4 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets slumped 66.53% in 2022, then jumped 494.21% in 2025.
- Corbus Pharmaceuticals Holdings' Prepaid Assets stood at $2.4 million in 2021, then plunged by 66.53% to $791616.0 in 2022, then surged by 209.24% to $2.4 million in 2023, then jumped by 48.24% to $3.6 million in 2024, then declined by 16.92% to $3.0 million in 2025.
- Business Quant data shows CRBP's Prepaid Assets at $3.0 million in Q4 2025, $3.3 million in Q3 2025, and $5.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 5.95 Mn |
| Mar 31, 2025 | 4.29 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 791,616.00 |
| Sep 30, 2022 | 926,161.00 |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 2.16 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 2.63 Mn |
| Mar 31, 2021 | 3.66 Mn |